Pharmacyclics, Inc. (NASDAQ:PCYC)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.

Results 1 - 20 of 38 : 1 2 Next »

Recs

1
Member Avatar marsuculix (21.12) Submitted: 9/29/2014 3:57:50 PM : Outperform Start Price: $120.54 PCYC Score: +3.17

Oct 7 is approaching - full marketing approval of imbruvica very likely...

Recs

0
Member Avatar StocksForLimits (< 20) Submitted: 8/4/2014 10:19:23 AM : Outperform Start Price: $118.30 PCYC Score: +2.68

I like the chart right here.

Recs

1
Member Avatar bdescent (69.39) Submitted: 6/27/2014 8:27:08 PM : Outperform Start Price: $89.58 PCYC Score: +37.65

Best in class treatment.

Recs

0
Member Avatar Staka (97.53) Submitted: 5/16/2014 10:15:00 AM : Underperform Start Price: $96.92 PCYC Score: -22.57

Long term mean reversion and increasing realism about possible profits will let more air out of this overvalued stock.

Recs

0
Member Avatar LMNOPQRStallion (32.27) Submitted: 5/14/2014 12:16:10 AM : Outperform Start Price: $100.06 PCYC Score: +20.11

The fool.com is worthless.

Recs

3
Member Avatar philiplbrooks (< 20) Submitted: 1/9/2014 4:57:40 PM : Outperform Start Price: $130.92 PCYC Score: -12.31

Imbruvica appears to be an amazing drug and has enormous potential in chronic lymphocytic lymphoma, low grade lymphomas and high grade lymphomas. Once in use, I think it will be used in multiple lines of treatment for these diseases and in combination with other new medications. It also has limited toxicities. Despite high expectations, I think it will outperform estimations.

Recs

0
Member Avatar PghTim (< 20) Submitted: 11/8/2013 12:00:36 PM : Outperform Start Price: $122.49 PCYC Score: -10.39

Ibrutinib is a potential blockbuster drug with a unique mechanism of action. It has the potential to be used in a number of indications.

Recs

1
Member Avatar wkeene (< 20) Submitted: 8/7/2013 6:13:11 PM : Outperform Start Price: $114.46 PCYC Score: -7.51

There is a lot of room for growth on this.

Recs

1
Member Avatar 50daymovingshort (43.14) Submitted: 4/10/2013 5:11:33 AM : Underperform Start Price: $75.45 PCYC Score: -38.94

This pick was made because its below the 50day moving average as of April 10th.
The whole list I perused through below 50dmva for 4/10/13 were;
AMZN,SIRI,PRAN,PCYC,CNQR,PCLN,CRM,LULU,CVLT,NFLX,ULTI,CTXS

These tickers were picked from my tracking universe of the following tickers:
CCI,AMZN,SIRI,LMT,PNRA,SBAC,RPRX,PRAN,MDVN,VZ,ALXN,PCYC,CNQR,INFI,VRTX,PCLN,CRM,LULU,CVLT,NFLX,OPEN,GMCR,N,CAR,REGN,T,SBUX,MO,ULTI,MAR,EQIX,CTXS,CLH,BLL

This was supposed to be a simple tracking blog post rather than a pitch but as a new player, it takes a couple of days to be approved for blog posting...oh well. Hopefully I remember to look back at these pitches.

Recs

1
Member Avatar mchedester (71.84) Submitted: 3/22/2013 4:47:10 PM : Outperform Start Price: $80.64 PCYC Score: +27.46

Great company with lots of cash that has been shooting up for a long time. I bought on the dip today and I'm buying in my motley fool caps as well.

Recs

0
Member Avatar buckeyefanboy (97.47) Submitted: 2/11/2013 12:52:10 PM : Outperform Start Price: $70.19 PCYC Score: +46.64

They're finally profitable and they got profitable in a big way.

Recs

0
Member Avatar PrototypeZ (23.98) Submitted: 2/4/2013 5:27:10 PM : Underperform Start Price: $70.30 PCYC Score: -45.27

Price levels are out of whack with fundamentals

Recs

0
Member Avatar tiredofit (< 20) Submitted: 1/30/2013 6:36:23 PM : Outperform Start Price: $68.01 PCYC Score: +50.81

outperform

Recs

1
Member Avatar lewrose (88.78) Submitted: 12/23/2012 1:37:57 PM : Outperform Start Price: $60.25 PCYC Score: +67.41

Game changing medication for several forms of leukemia, including CLL, about to be approved by FDA.

Recs

0
Member Avatar Imhilion (20.45) Submitted: 9/18/2012 12:24:21 AM : Underperform Start Price: $63.14 PCYC Score: -61.79

Parabolic technicals, stupidly overvalued fundamentals

Recs

2
Member Avatar BigFatBEAR (29.23) Submitted: 8/21/2012 1:56:17 AM : Underperform Start Price: $61.18 PCYC Score: -64.35

Eegads... don't think I've ever seen so many highly-ranked fools with -1000+ points associated as with this stock. Maybe shipping or solar, back in the day. Anyway, underperform...

Recs

0
Member Avatar TMFBiologyFool (96.59) Submitted: 7/2/2012 1:38:57 PM : Underperform Start Price: $57.52 PCYC Score: -70.61

Ibrutinib has potential, but risk reward is too unfavorable after the run up.

Recs

1
Member Avatar phatchips767 (< 20) Submitted: 6/27/2012 8:06:59 PM : Outperform Start Price: $53.90 PCYC Score: +80.98

went to 300% increase for potofeille.

Recs

1
Member Avatar GoodTrader1 (< 20) Submitted: 6/6/2012 4:38:42 PM : Outperform Start Price: $35.79 PCYC Score: +198.40

high relative strenght

Recs

2
Member Avatar wabiri (< 20) Submitted: 2/13/2012 4:16:29 PM : Outperform Start Price: $25.07 PCYC Score: +347.83

I think pcyc will hit $50.00 in 5years.

Results 1 - 20 of 38 : 1 2 Next »

Featured Broker Partners


Advertisement